Skip to main content
Animals : an Open Access Journal from MDPI logoLink to Animals : an Open Access Journal from MDPI
. 2026 May 18;16(10):1548. doi: 10.3390/ani16101548

Transcriptomic and Proteomic Analysis of the Skeletal Muscle Revealed the Effects and Mechanism of Mulberry Leaf Flavonoids on Alleviating Exercise-Induced Muscle Damage in Mongolian Horses

Aopan Geng 1,†, Xuejiao Wang 2,†, Lianhao Li 1, Sarah Cowie 3, Dongyi Bai 1, Manglai Dugarjaviin 1, Xinzhuang Zhang 1,*
Editor: Manfred Coenen
PMCID: PMC13203402  PMID: 42193839

Simple Summary

Prolonged high-intensity training in racehorses induces severe oxidative stress and muscle damage. Dietary supplementation with mulberry leaf extract effectively ameliorates these conditions, as evidenced by reduced blood biomarkers for inflammation and muscle injury. Furthermore, transcriptomic and proteomic analyses of muscle tissue demonstrated significant enrichment in specific cellular signaling pathways, suggesting that the extract potentially modulates protein metabolism and facilitating the restoration of damaged muscle fibers. These findings clarify the molecular mechanisms behind the antioxidant properties of mulberry extract and provide a clearer understanding of its potential as a targeted nutritional intervention for exercise-induced muscle damage.

Keywords: Mongolian horses, mulberry leaf flavonoids, exercise-induced muscle damage, transcriptomic, proteomic

Abstract

The scientific evidence regarding the use of plant-derived extracts to alleviate exercise-induced muscle damage in horses remains limited. Mulberry leaf flavonoids (MLFs) are the primary bioactive constituents of a traditional medicinal plant and are potent antioxidants. The aim of this study was to investigate the protective effects of MLFs against exercise-induced muscle damage. In this study, twelve Mongolian horses were used in a 3 × 3 Latin square design to investigate the protective effects of MLFs. Our results showed that high-intensity exercise negatively impacted the immune status, metabolic state, myofibrillar structure, and antioxidant capacity of the horses. Conversely, MLFs significantly reduced blood levels of white blood cells (WBC), monocytes (MON), aspartate aminotransferase (AST), creatine kinase (CK), and malondialdehyde (MDA) across various exercise distances and during recovery. Simultaneously, MLFs increased serum glutathione peroxidase (GPx), superoxide dismutase (SOD), and total antioxidant capacity (T-AOC). Mechanistically, transcriptomic analysis revealed that dietary MLFs upregulated genes associated with myofibrillar structural proteins (MYOZ2, MYOM3), the antioxidant defense system (GPX3, SOD3), and skeletal muscle satellite cell proliferation and differentiation (MYOD1, MRF6). Furthermore, quantitative proteomics indicated the enrichment of the PI3K-Akt and TGF-β signaling pathways, as well as ECM–receptor interactions, suggesting their potential involvement in regulating protein metabolism and facilitating myofibrillar restoration. Overall, MLFs effectively alleviated inflammation, metabolic disorder, and exercise-induced muscle damage. Under the tested conditions, a daily dosage of 10 g MLFs provided superior protective effects.

1. Introduction

Horse racing is an important economic industry in at least 71 countries worldwide, including developed nations such as the United States, Canada, and Japan [1]. This industry relies heavily on horses’ capacity for high-intensity exercise, while prolonged or intense exertion readily predisposes them to muscular injury, known as exercise-induced muscle damage (EIMD) [2]. Clinically, EIMD commonly presents with symptoms including impaired muscle force-producing capacity, decreased range of motion [3], delayed onset muscle soreness [4], and swelling of the affected limb. More specifically, the hallmark of EIMD involves two progressive injury processes: (1) primary muscle damage caused by repetition of non-uniform sarcomere lengthening and mechanical stress on a smaller number of muscle fibers, and (2) secondary muscle damage arising from calcium regulatory system disruption [5]. This calcium homeostasis imbalance further exacerbates tissue damage via inflammatory responses [6,7]. Simultaneously, high-intensity exercise enhances mitochondrial respiration to meet muscle oxygen and energy requirements, which in turn generates reactive oxygen species (ROS) including superoxide anions (O2•−), hydroxyl radicals (•OH), and hydrogen peroxide (H2O2) [8]. When the endogenous antioxidant defense mechanisms of the cell are overwhelmed, as occurs during excessive production of these ROS, horses may suffer from oxidative stress damage. This risk is not limited to specific horse types: endurance horses [9], show jumpers [10], and thoroughbred racehorses [11] are susceptible to oxidative stress during moderate- to high-intensity exercise [12]. Importantly, high ROS levels directly impair the muscle fiber membrane and mitochondria, leading to skeletal muscle contraction dysfunction and inducing muscle fatigue [13]. Oxidative stress is closely linked to most chronic inflammatory diseases [14].

Exogenous antioxidant supplements such as plant extracts [15] and coenzyme Q10 [16] are widely used in horses, and other supplements such as taurine [17] are widely used in humans to prevent or reduce exercise-induced muscle damage, spurring considerable research into their potential benefits. However, despite being a common practice among horse owners, trainers, veterinarians, and breeders, the application of plant extracts as exogenous antioxidant supplements to reduce exercise-induced oxidative damage in horses lacks peer-reviewed scientific evidence [15]. Information on their effects is primarily based on personal experiences rather than rigorous scientific research. Recent studies have explored the use of Silybum marianum and a combination of Verbascum thapsus, Curcuma longa, and Boswellia serrata in sport horses [18,19]. These plants display anti-inflammatory and antioxidant properties in vitro. However, no enhancement in antioxidant defenses was observed in these studies, as evidenced by the measurements of serum T-AOC, GPx activity, and the mRNA expression levels of NFE2L2 and SOD. Thus, further rigorous scientific research is needed to substantiate the efficacy of plant extracts as antioxidant supplements for enhancing equine performance and animal welfare.

Mulberry leaf serves not only as a traditional medicinal plant but also as a high-quality livestock forage. It is particularly rich in bioactive flavonoids—including morachalcone D, rutin, mulberroside, quercetin, kaempferol, and astragaloside [20] which demonstrate significant antioxidant and anti-inflammatory properties. Mulberry leaf flavonoids (MLFs) have been shown to activate the Nrf2 signaling pathway and enhance antioxidant defenses [21]. Moreover, chronic intake of flavonoids can stimulate mitochondrial biogenesis, thereby enhancing muscle energy supply and endurance [22]. Our in vitro studies showed that MLFs enhanced antioxidant enzyme activity, improved mitochondrial respiration, and boosted cellular energy metabolism effectively mitigating H2O2-induced oxidative damage in equine skeletal muscle satellite cells via the Nrf2 signaling pathway [23]. It should be noted that while MLFs show promise in vitro, their actual efficacy in vivo remains to be validated due to the potential low bioavailability and complex metabolism of flavonoids in the gastrointestinal tract. Based on these findings, we hypothesize that MLFs can mitigate muscle damage in horses during high-intensity exercise. Therefore, the aim of this study was to evaluate the protective effects of dietary MLF supplementation on exercise-induced muscle damage in Mongolian horses, and to elucidate the underlying molecular mechanisms through integrated transcriptomic and proteomic analysis.

2. Materials and Methods

2.1. Animals Management

Twelve healthy Mongolian stallions (aged 24 ± 1.5 months) with similar genetic backgrounds and body conformation were selected from Xilin Gol League, Inner Mongolia Autonomous Region. All horses were grazed on the same natural pasture for standardized adaptive training and confirmed to be free of clinical disease through baseline hematological screenings. Twelve horses were randomly assigned to three dietary treatments under free-grazing conditions: a control group (NC, 0 g/d) and two MLF-supplemented groups (Low, 5 g/d; High, 10 g/d) (Table S1). The MLFs (purity = 50%, solid powder) were manufactured by Shaanxi Sinuote Biotech Co., Ltd. (Xi’an, China), utilizing the extraction conditions previously optimized in our laboratory via response surface methodology (55% ethanol, 1:30 solid-liquid ratio, at 50 °C for 17 min). The primary chemical compositions of the MLFs were previously identified in our metabolomics study [23]. The daily MLFs dosage was dissolved in water and administered via oral drenching using a dosing syringe before morning grazing to ensure complete intake. Synchronously, the control group (0 g/d) was administered an equal volume of physiological saline via oral drenching.

2.2. Study Design

Using a replicated 3 × 3 Latin square design consisting of three 20 d periods separated by 15 d washout intervals to ensure metabolic clearance. At the end of each period, a 20 km high-intensity exercise test was conducted on a closed, fixed track (5 km per round trip) in Xilin Gol League, Inner Mongolia (altitude: 1377 ± 5 m). During the test, the horses were ridden by experienced riders at an average target speed of 14.6 km/h to ensure a high-intensity workload. Heart rate (HR) and running speed were monitored in real-time using a Polar Vantage VV watch paired with an H10 heart rate sensor (Polar Electro Oy, Kempele, Finland). Average heart rate and running speed did not differ significantly among the three treatments during the exercise test (p > 0.05, Table S2).

2.3. Sample Collection

Blood samples were collected via jugular venipuncture before (0 km), during (at 5 km and 20 km), and after (1 and 4 h post exercise). One blood sample was collected into EDTA-K2 anticoagulant tubes (Kangweishi, Shijiazhuang, China) for hematological analysis, and the other was centrifuged at low speed to collect the supernatant, which was stored at −80 °C for serum biochemical and antioxidant assays. Following the third 20 d feeding phase, muscle biopsies were performed at two time points: immediately after the 20 km exercise and again 24 h later. For each procedure, horses were sedated (butorphanol and detomidine, 0.02 mg/kg BW each), and samples were extracted from the gluteus medius muscle (5 cm) using a Bergström needle [24]. A 1 mm3 portion was fixed for transmission electron microscopy (TEM), while the remainder was snap-frozen in liquid nitrogen and stored at −80 °C for antioxidant and multiomics analyses.

2.4. Blood Parameters

Hematological parameters (WBC, Lymph, Mon, Gran, RBC, HGB) were analyzed using an automated analyzer (BC-2800VET, Mindray, Shenzhen, China). Serum biochemical parameters (LDH, ALP, AST, UREA, CREA, TC, TG, GLU, CK) were measured using a BS-180VET analyzer (Mindray, Shenzhen, China). Serum and muscle antioxidant markers (GPx, SOD, CAT, T-AOC, MDA) were assessed using commercial kits (Nanjing Jiancheng Bioengineering Institute) following the manufacturer’s protocols.

2.5. TEM Analyses

The 1 mm3 gluteus medius samples were fixed in 2.5% glutaraldehyde and 2% paraformaldehyde at 4 °C. After washes in 0.1 M phosphate buffer, tissues were fixed with 1% osmium tetroxide and 1.5% potassium ferrocyanide, stained with 1% uranyl acetate, dehydrated in an ethanol gradient, and embedded in epoxy resin. Ultrathin sections (80 nm) were cut using an ultramicrotome (EM UC7, Leica, Microsystems, Vienna, Austria), double-stained with uranyl acetate and lead citrate, and observed under a TEM (H-7650B, Hitachi, Tokyo, Japan).

2.6. Transcriptomic and Proteomic Analyses

Samples of gluteus medius muscle collected immediately after exercise and at 24 h post-exercise from horses in the NC (n = 3) and High (n = 4) groups were subjected to transcriptomic and proteomic sequencing (Shanghai Majorbio Biopharmaceutical Technology Co., Ltd., Shanghai, China). One horse in the NC group was excluded from the omics analysis due to the failure of obtaining a sufficient muscle biopsy sample. Briefly, for the transcriptomic workflow, total RNA was extracted from gluteus medius tissue and placed into RNase free centrifuge tubes. RNA quality was assessed using the Agilent 5300 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Qualified RNA samples underwent mRNA purification and fragmentation. cDNA synthesis was performed using PrimeScript™ RT Master Mix (catalog RR036A, Takara Bio, Kusatsu, Japan) to reverse transcribe the RNA. Library construction was carried out on an Illumina platform using the NovaSeq Reagent Kit (Illumina, San Diego, CA, USA), followed by sequencing of muscle-derived mRNA. Sequencing reads were trimmed and quality controlled with fastp software (https://github.com/OpenGene/fastp, accessed on 6 October 2025). Subsequently, the filtered clean reads were aligned to the Equus caballus reference genome using HISAT2 (http://ccb.jhu.edu/software/hisat2/index.shtml, accessed on 6 October 2025). Expression levels of genes and transcripts were quantified with RSEM software (http://deweylab.github.io/RSEM/, accessed on 6 October 2025). Gene abundance was quantified. Differential expression analysis was conducted using DESeq2 (http://bioconductor.org/packages/stats/bioc/DESeq2, accessed on 6 October 2025). Genes with |log2 fold change| > 2 and adjusted p ≤ 0.05 were defined as significantly differentially expressed genes (DEGs).

For the proteomic analysis: 100 mg of gluteus medius tissue was homogenized in lysis buffer (8 M urea and 1% SDS) containing PMSF, centrifuged at 12,000× g for 2 min, and the supernatant was quantified using a BCA assay. A total of 100 µg of quantified protein was brought to 90 µL with lysis buffer, reduced with TCEP at 37 °C for 60 min, alkylated with iodoacetamide in the dark at room temperature for 40 min, precipitated with acetone, resolubilized in 50 mmol/L TEAB, and digested overnight at 37 °C with trypsin at a 1:50 enzyme to protein ratios. The resulting peptides were labeled at room temperature with TMT reagents (incubated with acetonitrile for 2 h, reaction quenched with hydroxylamine), pooled in equal amounts, and vacuum dried. The peptide samples were first subjected to high pH reversed-phase liquid chromatography fractionation on an ACQUITY UPLC BEH C18 Column (1.7 µm, 2.1 mm × 150 mm, Waters, Milford, MA, USA) at room temperature, with a flow rate of 200 μL/min and a 48 min gradient elution. The collected fractions were combined and vacuum-concentrated, then subjected to nano LC-MS/MS analysis on a C18 column (75 μm × 25 cm, Thermo Fisher Scientific, Waltham, MA, USA) at room temperature (Easy-nLC 1200 coupled with Q Exactive HF-X mass spectrometer, Thermo Fisher Scientific, Waltham, MA, USA). The raw mass-spectrometry files were processed with a pre-established Equus caballus protein database (e.g., UniProt, NCBI protein libraries, or custom genome/transcriptome-specific databases) for search and analysis. Proteins showing an absolute expression fold change ≥1.2 and adjusted p ≤ 0.05 were defined as differentially expressed proteins (DEPs). KEGG pathway enrichment for DEGs and DEPs was performed, with Padjust < 0.05 indicating significant enrichment. All data analyses were conducted on the Majorbio Cloud Platform (www.majorbio.com). Differential expression analysis in the transcriptomic and proteomic data was conducted using two-tailed t-tests, with Benjamini–Hochberg p-value corrections applied to control the false discovery rate. KEGG enrichment for DEGs and DEPs was conducted using the clusterProfiler R package on the Majorbio Cloud Platform, utilizing a hypergeometric test to determine statistically significant pathway enrichment (adjusted p < 0.05).

2.7. Quantitative Real-Time PCR

The extraction of RNA from muscle tissue, followed by reverse transcription and quantitative PCR, was conducted using established methods [25]. Trizol reagent (Thermo Fisher Scientific, Inc., Boston, MA, USA) was employed to isolate total RNA from the muscle samples, which was then converted into cDNA with a reverse transcription kit (Takara Biotechnology Co., Ltd., Dalian, China). The primer sequences used are listed in Table S3. cDNA amplification was carried out using a CFX 96 Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA), with GAPDH serving as the internal control gene. The relative mRNA expression levels of the target genes were determined using the 2−ΔΔCt method.

2.8. Statistical Analysis

Hematological, biochemical, and antioxidant parameters were analyzed using the Linear Mixed Model (LMM) procedure in IBM SPSS Statistics 26.0 with a sample size of 12 horses. To correctly evaluate this crossover-style replicated Latin square design with repeated measures, the LMM included MLF dosage (M: 0, 5, or 10 g/d), recovery time (T: 0, 1, 4, 24 h) or exercise distance (D: 0, 5, and 20 km) and their interactions as fixed main effects, while the individual horse was modeled as a random effect. The normality of the standardized residuals was verified using Shapiro–Wilk tests. In the tabulated results, PM denotes the main effect of dietary MLFs supplementation, PD denotes the main effect of exercise distance, and PT denotes the main effect of post-exercise recovery time. The interaction effects between exercise distance and MLFs dosage and between rest time and MLFs dosage are represented by PD×M and PT×M, respectively. A Compound Symmetry covariance structure was applied to account for repeated measurements on the same animal. Estimated Marginal Means and corresponding Pooled Standard Errors Mean (SEM) were calculated, with post hoc pairwise comparisons performed using the Least Significant Difference test. Statistical significance was defined as p < 0.05.

3. Results

3.1. Hematological Parameters

All experimental groups maintained hematological parameters within normal reference ranges during both the exercise and post-exercise recovery periods (Table 1 and Table 2). Notably, there were no significant interaction effects between MLFs dosage and either exercise distance (PD×M > 0.05) or recovery time (PT×M > 0.05). Consequently, the main effects of dietary MLF supplementation and physical activity/rest were evaluated independently.

Table 1.

Effects of dietary MLF supplementation on hematological indices of horses at different exercise distances.

Item Dosage (g/d) 0 km 5 km 20 km Pooled SEM P D P M P D×M
WBC (109/L) 0 11.08 12.4 13.23 0.294 <0.001 0.001 0.864
5 10.25 11.68 12.78
10 9.7 10.3 11.2
Lymph (109/L) 0 3.95 4.87 5.4 0.171 <0.001 0.09 0.924
5 3.57 4.77 5.35
10 3.37 4.24 5.2
Mon (109/L) 0 0.6 0.7 0.81 0.018 <0.001 <0.001 0.651
5 0.56 0.62 0.72
10 0.5 0.55 0.62
Gran (109/L) 0 5.98 6.3 7.02 0.211 <0.001 0.046 0.684
5 5.43 6.15 6.83
10 4.98 5.98 6.69
RBC (1012/L) 0 6.77 7.65 7.08 0.197 0.003 0.002 0.997
5 7.77 8.49 8.02
10 7.13 8.08 7.48
HGB (g/L) 0 95.1 108 98.8 2.210 <0.001 <0.001 0.99
5 102 116.29 109.14
10 100.86 118.5 109

PD, PM, and PD×M represent the main effects of exercise distance, MLFs dosage, and their interaction, respectively.

Table 2.

Effects of dietary MLF supplementation on hematological indices of horses during the post-exercise recovery period.

Item Dosage (g/d) 0 h Post 1 h Post 4 h Post Pooled SEM P T P M P T×M
WBC (109/L) 0 13.23 12.2 11.58 0.285 0.001 0.001 0.875
5 12.78 11.68 10.58
10 11.2 10.9 9.8
Lymph (109/L) 0 5.4 4.4 3.85 0.150 <0.001 0.426 0.999
5 5.35 4.33 3.73
10 5.2 4.13 3.5
Mon (109/L) 0 0.81 0.7 0.62 0.018 <0.001 <0.001 0.677
5 0.72 0.64 0.58
10 0.62 0.56 0.53
Gran (109/L) 0 7.02 6.7 6.25 0.131 <0.001 0.024 0.595
5 6.83 6.4 6.1
10 6.69 6.3 5.38
RBC (1012/L) 0 7.08 6.38 6.95 0.201 0.278 0.001 0.758
5 8.02 7.72 7.7
10 7.48 7.29 7.21
HGB (g/L) 0 98.8 93.3 95.8 2.213 0.14 <0.001 0.938
5 109.14 104.71 102
10 109 103.38 106.08

PT, PM, and PT×M represent the main effects of post-exercise recovery time, MLFs dosage, and their interaction, respectively.

For leukocyte subpopulations (WBC, Mon, Gran, and Lymph), WBC, Mon, and Gran counts were lower in the MLF-supplemented groups in a dose-dependent manner, with the 10 g/d group maintaining the lowest levels compared to the 0 g/d and 5 g/d groups throughout both exercise and recovery (PM < 0.05). The main effect of MLFs on Lymph counts showed a trend toward reduction during exercise (PM = 0.090) but was not significant during recovery (PM = 0.426). During the exercise phase, these immune cells increased progressively from 0 to 20 km (PD < 0.05), but progressively decreased from 0 h to 4 h during the post-exercise recovery period (PT < 0.001). Regarding erythrocytic indices (RBC and HGB), levels were significantly higher in both the 5 g/d and 10 g/d MLF-supplemented groups across both phases (PM < 0.05), but also varied significantly with exercise distance, generally peaking at the 5 km mark (PD < 0.05). However, during the recovery phase, they remained relatively stable and were unaffected by rest time (PT > 0.05).

3.2. Biochemical Parameters

As presented in Table 3 and Table 4, there were no significant interaction effects between MLFs dosage and either exercise distance (PD×M > 0.05) or post-exercise recovery time (PT×M > 0.05) for any of the measured serum biochemical parameters. Therefore, the main effects of dietary treatment and exercise/recovery were analyzed independently.

Table 3.

Effects of dietary MLF supplementation on biochemical parameters of horses at different exercise distances.

Item Dosage (g/d) 0 km 5 km 20 km Pooled SEM P D P M P D×M
LDH (U/L) 0 262.4 262.92 285.64 6.553 0.008 0.041 0.983
5 263.33 255.67 282.33
10 248.27 238.1 267.78
ALP (U/L) 0 191.24 184 189.61 2.971 0.006 <0.001 0.517
5 225.66 214.72 225.94
10 220.48 198.14 207.6
AST (U/L) 0 267.83 280.53 294.1 6.243 <0.001 <0.001 0.565
5 228.43 222.4 258.83
10 204.43 218.97 253.93
UREA (mmol/L) 0 6.96 7.88 8.28 7.708 <0.001 0.003 0.852
5 6.74 7.62 7.84
10 6.52 7.44 7.46
CREA (mmol/L) 0 86.18 92.32 106.42 1.812 <0.001 0.012 0.997
5 83.43 90.43 104.08
10 78.93 85.05 97.42
TC (mmol/L) 0 1.61 1.69 1.82 0.021 <0.001 0.001 0.799
5 1.58 1.64 1.74
10 1.52 1.57 1.65
TG (mmol/L) 0 0.24 0.26 0.34 0.014 0.002 0.039 0.754
5 0.22 0.23 0.28
10 0.21 0.23 0.26
GLU (mmol/L) 0 3.55 4.65 5.17 0.137 <0.001 0.142 0.3
5 3.87 4.38 5.26
10 3.82 5.2 5.34
CK (mmol/L) 0 176.63 195.18 221.55 4.888 <0.001 <0.001 0.953
5 150.7 180.08 193.68
10 144.15 167.63 186.65

PD, PM, and PD×M represent the main effects of exercise distance, MLFs dosage, and their interaction, respectively.

Table 4.

Effects of dietary MLF supplementation on biochemical parameters of horses during the post-exercise recovery period.

Item Dosage (g/d) 0 h Post 1 h Post 4 h Post Pooled SEM P T P M P T×M
LDH (U/L) 0 285.64 285.05 278.54 6.828 0.978 0.056 0.892
5 282.33 288.9 289.8
10 267.78 262.92 272.54
ALP (U/L) 0 189.61 188.61 205.46 3.295 0.001 <0.001 0.265
5 225.94 224.3 232
10 207.6 221.58 238.28
AST(U/L) 0 294.1 282.06 276.6 6.033 0.002 <0.001 0.751
5 258.83 222.73 226.53
10 253.93 223.8 220.55
UREA (mmol/L) 0 8.28 8.03 7.14 0.104 <0.001 0.004 0.372
5 7.84 7.78 7.21
10 7.46 7.38 7
CREA (mmol/L) 0 106.42 95.12 89.2 1.776 <0.001 0.004 0.97
5 104.08 91.13 84.9
10 97.42 88.05 78.88
TC (mmol/L) 0 1.82 1.73 1.63 0.021 <0.001 <0.001 0.838
5 1.74 1.65 1.56
10 1.65 1.54 1.52
TG (mmol/L) 0 0.34 0.19 0.15 0.018 <0.001 0.322 0.902
5 0.28 0.18 0.14
10 0.26 0.13 0.13
GLU (mmol/L) 0 5.17 4.1 3.83 0.148 <0.001 0.456 0.425
5 5.26 3.87 3.86
10 5.34 4.48 3.78
CK (mmol/L) 0 221.55 201.85 184.03 4.804 <0.001 <0.001 0.977
5 193.68 183.98 160.13
10 186.65 176.13 153.7

PT, PM, and PT×M represent the main effects of post-exercise recovery time, MLFs dosage, and their interaction, respectively.

The serum activities of AST and CK were dose-dependently lower in the MLF-supplemented groups throughout both the exercise and recovery phases (PM < 0.001), with the 10 g/d group consistently exhibiting the lowest concentrations. Similarly, LDH levels were lower in the MLF-supplemented groups during exercise (PM = 0.041) and showed a trend toward reduction during recovery (PM = 0.056). ALP activity was significantly higher in the MLF-supplemented groups across both phases (PM < 0.001).

The concentrations of UREA, CREA, and TC were significantly lower in the MLF-supplemented groups across both experimental phases (PM < 0.05). TG levels were significantly lower in the MLF-supplemented groups during exercise (PM = 0.039) but did not differ significantly among groups during recovery (PM = 0.322). GLU remained unaffected by dietary treatments in both phases (PM > 0.05). During the exercise challenge, almost all monitored biochemical parameters, including AST, CK, UREA, CREA, TC, TG, and GLU, increased progressively from 0 to 20 km (PD < 0.05). Conversely, during the post-exercise recovery period, the serum concentrations of these same parameters progressively declined from 0 h to 4 h (PT < 0.05). Meanwhile, LDH remained relatively stable during rest (PT = 0.978), whereas ALP activity continued to increase (PT = 0.001).

3.3. Antioxidant Indices in Serum

As shown in Table 5 and Table 6, no significant interaction effects were observed between MLFs dosage and either exercise distance (PD×M > 0.05) or post-exercise recovery time (PT×M > 0.05) for any serum antioxidant indices. Consequently, the main effects of dietary treatment and exercise/recovery were analyzed independently.

Table 5.

Effects of dietary MLF supplementation on serum antioxidant indices of horses at different exercise distances.

Item Dosage (g/d) 0 km 5 km 20 km Pooled SEM P D P M P D×M
T-AOC (mM) 0 0.47 0.43 0.34 0.014 <0.001 <0.005 0.814
5 0.49 0.46 0.41
10 0.52 0.49 0.44
SOD (U/mL) 0 16.68 14.99 13.44 0.403 <0.001 0.001 0.964
5 18.85 16.77 14.66
10 19.35 17.1 15.58
CAT (U/mL) 0 11.36 11.28 10.42 0.244 <0.004 0.623 0.991
5 11.65 11.43 10.56
10 11.83 11.39 10.67
GPx (U/mL) 0 356.67 345.8 313.97 4.721 <0.001 <0.001 0.815
5 381.74 359.84 336.06
10 393.78 369.12 355.9
MDA (nmol/mL) 0 7.36 8.32 9.07 0.353 <0.007 <0.001 0.979
5 6.48 7.07 8.15
10 5.67 6.22 6.89

PD, PM, and PD×M represent the main effects of exercise distance, MLFs dosage, and their interaction, respectively.

Table 6.

Effects of dietary MLF supplementation on serum antioxidant indices of horses during the post-exercise recovery period.

Item Dosage (g/d) 0 h Post 1 h Post 4 h Post Pooled SEM P T P M P T×M
T-AOC (mM) 0 0.34 0.38 0.43 0.012 0.026 <0.001 0.105
5 0.41 0.44 0.47
10 0.44 0.47 0.51
SOD (U/mL) 0 13.44 15.26 16.22 0.374 <0.001 <0.001 0.595
5 14.66 15.83 18.64
10 15.58 18.03 19.38
CAT (U/mL) 0 10.42 10.59 10.75 0.246 0.131 0.179 0.936
5 10.56 10.88 11.31
10 10.67 11.27 11.65
GPx (U/mL) 0 313.97 338.03 352.17 4.726 <0.001 <0.001 0.771
5 336.06 351.76 371.33
10 355.9 363.9 397.91
MDA (nmol/mL) 0 9.07 8.29 7.59 0.262 0.001 <0.001 0.5
5 8.15 8.14 6.07
10 6.89 6.66 5.86

PT, PM, and PT×M represent the main effects of post-exercise recovery time, MLFs dosage, and their interaction, respectively.

T-AOC, SOD, and GPx activities were higher in the MLF-supplemented groups in a dose-dependent manner across both the exercise and recovery phases, with the 10 g/d group maintaining the highest levels compared to the 0 g/d and 5 g/d groups (PM < 0.05). Conversely, serum MDA concentrations were dose-dependently lower in the MLF-supplemented groups in both phases, with the 10 g/d group exhibiting the lowest levels (PM < 0.001). The main effect of MLFs on CAT activity was not significant in either experimental phase (PM > 0.05). During the exercise phase, the serum activities of T-AOC, SOD, CAT, and GPx progressively decreased from 0 to 20 km, while MDA concentrations progressively increased (PD < 0.05). Conversely, during the post-exercise recovery period, T-AOC, SOD, and GPx activities progressively increased from 0 h to 4 h (PT < 0.05), accompanied by a progressive decrease in MDA concentrations (PT = 0.001). Meanwhile, CAT activity remained stable during the recovery phase and was unaffected by rest time (PT = 0.131).

3.4. Antioxidant Indices in Muscle

As presented in Table 7, no significant interaction effects were observed between MLFs dosage and post-exercise recovery time for any of the measured muscle antioxidant indices (PT×M > 0.05). Consequently, the main effects of dietary treatment and recovery time were evaluated independently. The muscle activities of T-AOC, SOD, CAT, GPx, and the concentration of MDA did not differ significantly between the 10 g/d MLFs group and the 0 g/d group (PM > 0.05). Muscle T-AOC levels exhibited a progressive increase from 0 h to 24 h post-exercise (PT = 0.02). However, the muscle activities of SOD, CAT, and GPx, as well as MDA concentrations, remained statistically unchanged during this 24 h recovery window (PT > 0.05).

Table 7.

Effects of dietary MLF supplementation on muscle antioxidant indices of horses during the post-exercise recovery period.

Item Dosage (g/d) 0 h Post 24 h Post Pooled SEM P T P M P T×M
T-AOC (mM) 0 0.15 0.34 0.061 0.02 0.512 0.61
10 0.16 0.45
SOD (U/mL) 0 31.64 42.11 5.217 0.194 0.256 0.954
10 40.72 50.36
CAT (U/mL) 0 20.74 32.21 2.773 0.373 0.447 0.618
10 30.87 34.57
GPx (U/mL) 0 762.6 794.87 88.801 0.666 0.559 0.862
10 814.31 889.44
MDA (nmol/mL) 0 6.53 4.3 0.920 0.113 0.358 0.937
10 5.26 3.22

PT, PM, and PT×M represent the main effects of post-exercise recovery time, MLFs dosage, and their interaction, respectively.

3.5. Myofibrillar Structure

Qualitative morphological evaluation of the gluteus medius muscle via TEM is presented in Figure 1. Immediately following the 20 km exercise (0 h post-exercise), the myofibrillar architecture in the NC group exhibited localized disorganization, characterized by irregular Z-line alignment and less distinct sarcomere banding (Figure 1A–C). In contrast, the High-MLFs group (10 g/d) displayed distinctly aligned Z-lines, intact myofilaments, and clearly identifiable A-bands, I-bands, H-zones, and M-lines (Figure 1D–F).

Figure 1.

Figure 1

Effects of MLFs on myofibrillar structure in Mongolian horses at 0 h and 24 h post-exercise. (A–C) NC treatment: 10,000×, 20,000× and 30,000×. (D–F) High treatment: 10,000×, 20,000× and 30,000×. (G–I) NC 24 treatment: 10,000×, 20,000× and 30,000×. (J–L) High 24 treatment: 10,000×, 20,000× and 30,000×.

At 24 h post-exercise, residual structural irregularities, including slight focal misalignment of Z-lines, remained visible in the NC group (Figure 1G–I). Conversely, the High-MLFs group maintained a highly organized and tightly packed sarcomere structure, demonstrating continuous, straight Z-lines and distinct cross-striations across the observed magnifications (Figure 1J–L).

3.6. Transcriptomic Analysis

To investigate the gene expression profiles in the gluteus medius following MLFs intervention, transcriptomic analysis was performed on Mongolian horses treated with 10 g/d MLFs. After 20 km exercise, 498 DEGs were upregulated and 212 DEGs were downregulated in the MLFs group compared to the NC group (Figure 2A). At 24 h post-exercise, 21 DEGs were upregulated and four DEGs were downregulated in the MLFs group (Figure 2B). Transcriptomic KEGG functional enrichment analysis revealed that after 20 km exercise, ECM–receptor interaction, PI3K-Akt signaling pathway, AGE-RAGE signaling pathway in diabetic complications, and TGF-beta signaling pathway were among the top nine enriched KEGG pathways (Figure 2C) (adjusted p < 0.05). Genes involved in these four signaling pathways exhibited significant coordinated changes in the skeletal muscle of MLF-treated horses. For instance, TGFB1, TGFB3, TGFBR2, and THBS1 were significantly upregulated in the MLFs group (Figure S1A). Similar dynamic changes were observed in key genes involved in the PI3K-Akt signaling pathway (e.g., IGF2, PPP2R2D, and PPP2R5), ECM remodeling (e.g., COL1A1, COL1A2, COL6A3, and COL14A1), and AGE-RAGE signaling pathway in diabetic complications (e.g., SELE, ICAM1, MAPK12, and JUN) (Figure S1B–D). GSEA analysis further confirmed the changes in these four signaling pathways (Figure 3). Notably, transcriptomic data also revealed significant differences in the expression of core genes associated with skeletal muscle myogenesis and myofiber function. Compared with the 0 g/d MLFs group, the mRNA level of MYOD was significantly upregulated. Additionally, the mRNA levels of MYOZ2, MYOM3, SOD3 and GPX3 were significantly upregulated, whereas MRF6 was significantly downregulated (Figure S1E–G). As shown in Figure S2, the expression trends at 0 h and 24 h post-exercise were highly consistent with the RNA-seq data, confirming the robustness of our transcriptomic results.

Figure 2.

Figure 2

Comparison of skeletal muscle transcriptomic profiles between NC and High-treated Mongolian horses. (A,B) Volcano plots. (C,D) KEGG pathway enrichment. The pathways highlighted with red boxes indicate the key signaling pathways of interest discussed in this study. Due to layout constraints in the plotting software, truncated pathway names in the figure represent “AGE-RAGE signaling pathway in diabetic complications” in (C) and “Non-alcoholic fatty liver disease (NAFLD)” in (D).

Figure 3.

Figure 3

GSEA of key signaling pathways in skeletal muscle. (A) ECM–receptor interaction. (B) TGF-beta signaling pathway. (C) PI3K-Akt signaling pathway. (D) AGE-RAGE signaling pathway in diabetic complications.

3.7. Proteomics Analysis

Furthermore, we analyzed the proteomic profiles of Mongolian horse muscle tissue based on the TMT-based quantitative proteomic approach. After 20 km exercise and at 24 h post-exercise, 25 and 40 DEPs were identified between the MLF-supplemented group and the NC group, respectively (Figure 4A,B). These proteins were subjected to visualized analysis via KEGG pathway enrichment (Figure 4D). Among these, the top 10 differential signaling pathways included the TGF-beta signaling pathway, PPAR signaling pathway, and ECM–receptor interaction (adjusted p < 0.05). Subsequent PSEA revealed that the expression levels of proteins associated with the ECM–receptor interaction and TGF-beta signaling pathway were higher in the MLFs group, whereas those associated with the PPAR signaling pathway were lower (Figure 5A,B). Consistent with these findings, targeted analysis at 24 h post-exercise demonstrated a significant upregulation of key proteins in the TGF-beta signaling pathway (e.g., COL6A3, COL6A6, COL14A1, and CFP) and ECM–receptor interaction networks (e.g., DCN, PRELP, LUM, and ASPN). Conversely, core proteins involved in the PPAR signaling pathway (such as ACADS, HADHA, ACAT1, and IVD) were significantly downregulated in the High-MLFs group (Figure S3).

Figure 4.

Figure 4

Comparison of skeletal muscle proteomic profiles between NC and High-treated Mongolian horses. (A,B) Volcano plots. (C,D) KEGG pathway enrichment. The pathways highlighted with red boxes indicate the key signaling pathways of interest discussed in this study. Due to layout constraints in the plotting software, truncated pathway names in the figure represent “Metabolism of xenobiotics by cytochrome P450” and “Aldosterone synthesis and secretion” in (C), and “Valine, leucine and isoleucine degradation” in (D).

Figure 5.

Figure 5

PSEA of key signaling pathways in skeletal muscle. (A) TGF-beta signaling pathway. (B) PPAR signaling pathway. (C) ECM–receptor interaction.

4. Discussion

The aim of this study was to evaluate the protective effects of MLFs against exercise-induced muscle damage and to elucidate the underlying molecular mechanisms. The primary outcomes of this study reveal a robust correlation between the intervention with MLFs and the amelioration of blood biomarkers associated with oxidative stress, inflammation, and muscle damage in horses subjected to high-intensity exercise, suggesting the potential therapeutic significance of MLFs. Mongolian horses receiving MLFs exhibited significant changes in physiological parameters, including reduced immune cell counts, CK, and MDA levels. Notably, the optimal effect was observed at a dosage of 10 g. Indeed, numerous studies have shown the potential of MLFs, such as kaempferol [14], astragalin [26], and Mulberrin [27], in improving the antioxidant and anti-inflammatory status of animals.

The changes in hematological parameters induced by high-intensity exercise in horses in the present study are largely consistent with those previously described in human and equine studies [28,29]. High-intensity exercise led to increased levels of WBC, Lymph, Mon, and Gran in horses, consistent with reports by Johanna et al. [28] and Andriichuk et al. [30]. The increase in WBC is one of the common physiological responses to exercise, typically occurring after all types of physical activity [31]. The increase in WBC during exercise is biphasic, initially involving the mobilization of lymphocytes, followed by the mobilization of neutrophils and monocytes [32]. The exercise-induced leukocytosis is often likened to an inflammatory response, with the increase in WBC being proportional to the intensity of the immune system’s response to physiological stress [33,34]. Horses fed MLFs showed significant decrease in WBC, Mon, and Gran levels. Collectively, evidence in earlier studies and findings support that MLF can provide benefits in minimizing inflammatory response. Furthermore, the elevated RBC and HGB levels after the 20 km exercise potentially provide the physiological basis for enhanced oxygen transport, enabling better endurance and strength. However, further studies are needed to validate their functional effects on equine performance. These facilitative effects of MLFs are consistent with previous studies [14] indicating that MLFs possess anti-inflammatory and immunomodulatory effects, potentially aiding in the reduction in exercise-induced inflammatory responses.

Excessive exercise generates abundant ROS that can compromise the integrity of cellular membranes, leading to the leakage of numerous intracellular metabolites and proteins from muscle cells into the systemic circulation, particularly CK, LDH, and AST [35]. Horses supplemented with MLFs in the present study exhibited reductions in serum AST and CK levels. The reduction in CK levels is likely due to the antioxidant properties of MLFs, which can neutralize ROS produced during the electron transport chain in oxidative phosphorylation [36]. Another possibility for the decrease in CK levels is that MLFs could reduce the permeability of the vascular membrane, thereby reducing the flow of CK from inside cells to the bloodstream [37]. Although the serum CK levels in horses in this study remained within the normal reference range, an increase was observed after each exercise session. This observation is in line with expectations from the previous literature [38] and indicates that high-intensity exercise over 20 km is sufficient to cause muscle cell disturbance in this study. Considering that AST is a critical marker for liver health and CK for muscle damage in animals following acute exercise, the findings imply that MLFs exert a protective influence on both the liver and muscles.

The rise in ROS after high intensity exercise is thought to cause secondary damage to uninjured muscle fibers either by direct oxidative injury to biomolecules or by indirectly inducing inflammatory cytokines [39,40]. MDA is a well-recognized biomarker of oxidative stress, as it reflects the peroxidative damage caused by ROS to polyunsaturated fatty acids [41]. Meanwhile, in biological systems, CAT, SOD, and GPx are regarded as the three most potent antioxidant enzymes, acting as the primary defense against ROS [42]. Several studies have confirmed the increased lipid peroxidation during different forms of physical activity in sport horses [43,44,45]. Similarly, in the present study, MDA concentration increased significantly after physical activity, while a significant decrease after 24 h of rest was observed. It is noteworthy that during exercise and the subsequent 4 h recovery period dietary MLF supplementation significantly reduced the MDA concentration in Mongolian horses and increased serum T AOC, GPx and SOD activities. These results suggest that MLFs are associated with the mitigation of lipid peroxidation caused by exercise, aligning with findings from prior studies conducted on mouse models [46]. However, no statistically significant differences were observed in the antioxidant indices within the muscle tissue. This unforeseen result may be associated with the first-pass effect of MLFs in the liver [47], which reduces their bioavailability through ongoing metabolism and transport. Traditional view holds that flavonoids can directly scavenge excessive free radicals in the body. However, studies have shown that among the flavonoids taken orally, less than 5% can enter the blood circulation, and the remaining approximately 95% are fermented and decomposed by the intestinal flora [48]. Even so, the ability of flavonoids to alleviate EIMD lies in cell signaling stress response pathways, thereby enhancing the transcription of endogenous antioxidant enzymes [49,50]. In line with this mechanism, our data revealed an upregulation of GPX3 and SOD3 mRNA levels following MLF supplementation, pointing toward a potential activation of endogenous antioxidant defenses against exercise-induced oxidative stress at the transcriptional level.

Primary muscle injury is characterized by progressive degradation of muscle fibers, disruption of sarcomeric architecture, Z-line streaming, and loss of essential cytoskeletal proteins [51]. In our experiment, horses subjected to a 20 km exercise exhibited clear muscle fiber damage; although some recovery of myofibrillar structure was observed after a 24 h recovery period, the lack of distinct I Band and the tortuosity of the Z-line suggest that complete recovery of myofibrillar structure after intense exercise may require more than 24 h. In the MLFs treatment, horses showed better recovery states immediately post-exercise and at the 24 h mark. Further transcriptomic data indicate that pretreatment with MLFs significantly upregulates the mRNA expression of MYOZ2 and MYOM3 in horse skeletal muscle. Previous studies have shown that the MYOZ2 and MYOM3 genes, by encoding core structural proteins of the Z-line and M-line in muscle fibers respectively, play an important role in preserving muscle structural integrity [52,53]. Myogenesis is the principal repair mechanism after muscle injury, governed by differential expression of myogenic regulatory factors (MRFs); MyoD promotes satellite cell activation toward the myogenic lineage, whereas MRF6 mainly controls terminal differentiation of myoblasts [54,55]. In this study, the mRNA expression of MYOD1 was significantly upregulated, whereas that of MRF6 was significantly downregulated, indicating that MLFs may accelerate the regeneration and repair of injured muscle fibers by promoting early satellite cell activation and proliferation. Concordantly, this is consistent with our observations in myofibrillar structure. Through KEGG enrichment analysis of skeletal muscle samples from horses collected immediately post-exercise and 24 h later, it is suggested that the PI3K/AKT pathway, TGF-β pathway, and ECM–receptor interaction, as the most significantly co-enriched pathways at both post-exercise time points, play important roles in MLF-mediated mitigation of exercise-induced muscle injury in horses.

The core of myofiber injury lies in an imbalance between protein synthesis and degradation (i.e., synthesis rate < degradation rate) [56]. Reported evidence indicates that skeletal muscle protein synthesis and degradation are regulated by the mechanistic target of rapamycin (mTOR) pathway and the ubiquitin–proteasome system [57]. The PI3K/Akt pathway serves as a key upstream axis that activates both the mTOR and FOXO signaling cascades [58]. Concurrently, the TGF-β pathway positively regulates muscle protein synthesis [59]. Among these, bone morphogenetic proteins, members of the TGF-β superfamily, can promote skeletal–muscle hypertrophy by activating the mTOR pathway and the SMAD1/5/8 cascade [60]. Evidence shows that mulberry leaf flavonoids activate PI3K/AKT/mTOR and TGF-β pathways, thereby enhancing skeletal–muscle development in broiler chickens [61]. Similarly, in mouse models, active constituents of mulberry leaves activate the TGF-β/Smad pathway, alleviating oxidative-stress-induced renal fibrosis [62]. Moreover, TGF-β (particularly TGFB1) is among the earliest cytokines upregulated after tissue injury, regulating ECM synthesis, remodeling, and degradation [63,64]. During muscle repair, TGF-β activates transcription of genes encoding core ECM proteins, such as COL1A1, COL1A2 (type I collagen subunits) and FN1 (fibronectin), thereby furnishing a structural scaffold for myofiber regeneration [65]. Collectively, these findings imply that MLFs may mitigate exercise-induced muscle injury in horses by modulating these specific pathways to favor protein synthesis and structural recovery. While our omics data highlight potential pathways, future functional studies are necessary to confirm the precise signaling mechanisms underlying the protective effects of MLFs.

5. Conclusions

In summary, this study supports that MLFs play an important role in the process of mitigating high-intensity exercise-induced muscle damage in Mongolian horses. The comprehensive hemotological and cytological data indicate that the processes involved include attenuation of inflammatory responses, correction of metabolic disturbances, regulation of protein metabolic balance, upregulation of structural proteins, activation of antioxidant defenses, and promotion of the proliferation and differentiation of skeletal muscle satellite cells. Therefore, MLF supplementation may represent an effective phytotherapy for reducing oxidative stress and muscle damage induced by strenuous exercise. Within the tested range, the 10 g/d dose provided more effective protection than the 5 g/d dose.

Abbreviations

The following abbreviations are used in this manuscript:

NC Normal Control
Low Low-Dose MLFs Treatment
MLFs Mulberry leaf flavonoids
EIMD Exercise-induced muscle damage
ROS Reactive oxygen species
WBC White blood cells
Lymph Lymphocyte count
Mon Monocyte count
Gran Granulocyte count
RBC Red blood cell count
HGB Hemoglobin
AST Aspartate aminotransferase
CREA Creatinine
LDH Lactate dehydrogenase
ALP Alkaline phosphatase
TC Total Cholesterol
TG Triglycerides
GLU Glucose
CK Creatine Kinase
GPx Glutathione peroxidase
SOD Superoxide dismutase
CAT Catalase
T-AOC Total antioxidant capacity
MDA Malondialdehyde
TEM Transmission electron microscope
DEGs Differentially expressed genes
DEPs Differentially expressed proteins
GSEA Gene Set Enrichment Analysis
PSEA Protein Set Enrichment Analysis
LMM Linear Mixed Model
SEM Standard Error of the Mean

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ani16101548/s1, Figure S1: Expression profiles of key DEGs identified from transcriptomic analysis at 0 h post-exercise. Bar charts illustrating the mRNA expression levels of representative DEGs involved in the (A) TGF-beta signaling pathway, (B) PI3K-Akt signaling pathway, (C) ECM–receptor interaction, (D) AGE-RAGE signaling pathway, (E) Myogenic regulatory factors, (F) Sarcomeric protein genes, and (G) Antioxidant enzyme genes. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001; Figure S2: Comparison of RNA Seq and RT-q PCR results in both NC vs. High (A) and NC 24 vs. High 24 comparison groups (B). Figure S3. Expression profiles of key DEPs involved in core signaling pathways at 24 h post-exercise. Bar charts illustrating the relative expression levels of representative proteins associated with the (A) TGF-beta signaling pathway, (B) ECM–receptor interaction, and (C) PPAR signaling pathway in the skeletal muscle of the NC and High-MLFs groups. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001; Table S1. Groups by Latin square test method; Table S2. Effects of dietary MLF supplementation on average heart rate and average speed of horses during exercise; Table S3. Primers sequence.

animals-16-01548-s001.zip (444.4KB, zip)

Author Contributions

Conceptualization, X.Z. and M.D.; methodology, X.Z.; formal analysis, A.G. and X.W.; investigation, L.L. and D.B.; writing—original draft preparation, A.G. and X.W.; writing—review and editing, X.Z. and S.C.; project administration, X.Z. and M.D.; funding acquisition, X.Z. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

The feeding procedures and sample collections complied with the guidelines approved by the Animal Welfare Committee of Inner Mongolia Agricultural University (Permit No: NND2023019).

Informed Consent Statement

Not applicable.

Data Availability Statement

All data generated or analyzed during this study are included in this published article.

Conflicts of Interest

The authors declare no conflicts of interest.

Funding Statement

This research was funded by the Outstanding Youth Science Fund Training Project of Inner Mongolia Agricultural University (BR230405); the National Natural Science Foundation of China (31902188, U23A20224); the Inner Mongolia Education Department Special Research Project For First Class Disciplines (YLXKZX-NND-007); and the Key R&D project of Inner Mongolia (2023YFDZ0002), High-level Achievement Cultivation Project of College of Animal Science, Inner Mongolia Agricultural University (CG202421).

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Legg K.A., Gee E.K., Breheny M., Gibson M.J., Rogers C.W. A Bioeconomic Model for the Thoroughbred Racing Industry—Optimisation of the Production Cycle with a Horse Centric Welfare Perspective. Animals. 2023;13:479. doi: 10.3390/ani13030479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Tee J.C., Bosch A.N., Lambert M.I. Metabolic Consequences of Exercise-Induced Muscle Damage. Sports Med. 2007;37:827–836. doi: 10.2165/00007256-200737100-00001. [DOI] [PubMed] [Google Scholar]
  • 3.Harty P.S., Cottet M.L., Malloy J.K., Kerksick C.M. Nutritional and Supplementation Strategies to Prevent and Attenuate Exercise-Induced Muscle Damage: A Brief Review. Sports Med.-Open. 2019;5:1. doi: 10.1186/s40798-018-0176-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Salem A., Ben Maaoui K., Jahrami H., AlMarzooqi M.A., Boukhris O., Messai B., Clark C.C.T., Glenn J.M., Ghazzaoui H.A., Bragazzi N.L., et al. Attenuating Muscle Damage Biomarkers and Muscle Soreness after an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-Analysis with Meta-Regression. Sports Med.-Open. 2024;10:42. doi: 10.1186/s40798-024-00686-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Markus I., Constantini K., Hoffman J.R., Bartolomei S., Gepner Y. Exercise-Induced Muscle Damage: Mechanism, Assessment and Nutritional Factors to Accelerate Recovery. Eur. J. Appl. Physiol. 2021;121:969–992. doi: 10.1007/s00421-020-04566-4. [DOI] [PubMed] [Google Scholar]
  • 6.Tanabe Y., Fujii N., Suzuki K. Dietary Supplementation for Attenuating Exercise-Induced Muscle Damage and Delayed-Onset Muscle Soreness in Humans. Nutrients. 2021;14:70. doi: 10.3390/nu14010070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Proske U., Morgan D.L. Muscle Damage from Eccentric Exercise: Mechanism, Mechanical Signs, Adaptation and Clinical Applications. J. Physiol. 2001;537:333–345. doi: 10.1111/j.1469-7793.2001.00333.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Powers S.K., Jackson M.J. Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production. Physiol. Rev. 2008;88:1243–1276. doi: 10.1152/physrev.00031.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Brkljača Bottegaro N., Gotić J., Šuran J., Brozić D., Klobučar K., Bojanić K., Vrbanac Z. Effect of Prolonged Submaximal Exercise on Serum Oxidative Stress Biomarkers (d-ROMs, MDA, BAP) and Oxidative Stress Index in Endurance Horses. BMC Vet. Res. 2018;14:216. doi: 10.1186/s12917-018-1540-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Soares J.C.M., Zanella R., Bondan C., Alves L.P., de Lima M.R., da Motta A.C., Zanella E.L. Biochemical and Antioxidant Changes in Plasma, Serum, and Erythrocytes of Horses before and after a Jumping Competition. J. Equine Vet. Sci. 2011;31:357–360. doi: 10.1016/j.jevs.2011.03.017. [DOI] [Google Scholar]
  • 11.White A., Estrada M., Walker K., Wisnia P., Filgueira G., Valdés F., Araneda O., Behn C., Martínez R. Role of Exercise and Ascorbate on Plasma Antioxidant Capacity in Thoroughbred Race Horses. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2001;128:99–104. doi: 10.1016/S1095-6433(00)00286-5. [DOI] [PubMed] [Google Scholar]
  • 12.De Moffarts B., Kirschvink N., Art T., Pincemail J., Lekeux P. Effect of Exercise on Blood Oxidant/Antioxidant Markers in Standardbred Horses: Comparison between Treadmill and Race Track Tests. Equine Vet. J. 2006;38:254–257. doi: 10.1111/j.2042-3306.2006.tb05548.x. [DOI] [PubMed] [Google Scholar]
  • 13.Wang F., Wang X., Liu Y., Zhang Z. Effects of Exercise-Induced ROS on the Pathophysiological Functions of Skeletal Muscle. Oxid. Med. Cell. Longev. 2021;2021:3846122. doi: 10.1155/2021/3846122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lin Z., Gan T., Huang Y., Bao L., Liu S., Cui X., Wang H., Jiao F., Zhang M., Su C., et al. Anti-Inflammatory Activity of Mulberry Leaf Flavonoids In Vitro and In Vivo. Int. J. Mol. Sci. 2022;23:7694. doi: 10.3390/ijms23147694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Elghandour M.M.M.Y., Kanth Reddy P.R., Salem A.Z.M., Ranga Reddy P.P., Hyder I., Barbabosa-Pliego A., Yasaswini D. Plant Bioactives and Extracts as Feed Additives in Horse Nutrition. J. Equine Vet. Sci. 2018;69:66–77. doi: 10.1016/j.jevs.2018.06.004. [DOI] [Google Scholar]
  • 16.Henry M.L., Wesolowski L.T., Pagan J.D., Simons J.L., Valberg S.J., White-Springer S.H. Impact of Coenzyme Q10 Supplementation on Skeletal Muscle Respiration, Antioxidants, and the Muscle Proteome in Thoroughbred Horses. Antioxidants. 2023;12:263. doi: 10.3390/antiox12020263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Canals-Garzón C., Guisado-Barrilao R., Martínez-García D., Chirosa-Ríos I.J., Jerez-Mayorga D., Guisado-Requena I.M. Effect of Antioxidant Supplementation on Markers of Oxidative Stress and Muscle Damage after Strength Exercise: A Systematic Review. Int. J. Environ. Res. Public Health. 2022;19:1803. doi: 10.3390/ijerph19031803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Beghelli D., Zallocco L., Angeloni C., Bistoni O., Ronci M., Cavallucci C., Mazzoni M.R., Nuccitelli A., Catalano C., Hrelia S., et al. Dietary Supplementation with Boswellia Serrata, Verbascum Thapsus, and Curcuma Longa in Show Jumping Horses: Effects on Serum Proteome, Antioxidant Status, and Anti-Inflammatory Gene Expression. Life. 2023;13:750. doi: 10.3390/life13030750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Dockalova H., Baholet D., Batik A., Zeman L., Horky P. Effect of Milk Thistle (Silybum marianum) Seed Cakes by Horses Subjected to Physical Exertion. J. Equine Vet. Sci. 2022;113:103937. doi: 10.1016/j.jevs.2022.103937. [DOI] [PubMed] [Google Scholar]
  • 20.Chan E.W.-C., Lye P.-Y., Wong S.-K. Phytochemistry, Pharmacology, and Clinical Trials of Morus alba. [(accessed on 12 May 2026)];Chin. J. Nat. Med. 2016 14:17–30. doi: 10.3724/SP.J.1009.2016.00017. Available online: https://www.sciencedirect.com/science/article/pii/S187553641630005X. [DOI] [PubMed] [Google Scholar]
  • 21.Chen Y., Lai L., Mo Z., Li X., Su X., Li Y., Leng E., Zhang Y., Li W. Mulberry Leaf Extract Alleviates Staphylococcus Aureus-Induced Conjunctivitis in Rabbits via Downregulation of NLRP3 Inflammasome and Upregulation of the Nrf2 System and Suppression of pro-Inflammatory Cytokines. Pharmacology. 2022;107:250–262. doi: 10.1159/000523786. [DOI] [PubMed] [Google Scholar]
  • 22.Munguía L., Ortiz M., González C., Portilla A., Meaney E., Villarreal F., Nájera N., Ceballos G. Beneficial Effects of Flavonoids on Skeletal Muscle Health: A Systematic Review and Meta-Analysis. J. Med. Food. 2022;25:465–486. doi: 10.1089/jmf.2021.0054. [DOI] [PubMed] [Google Scholar]
  • 23.Zhang X., Geng A., Cao D., Dugarjaviin M. Identification of Mulberry Leaf Flavonoids and Evaluating Their Protective Effects on H2O2-Induced Oxidative Damage in Equine Skeletal Muscle Satellite Cells. Front. Mol. Biosci. 2024;11:1353387. doi: 10.3389/fmolb.2024.1353387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bou T., Ding W., Ren X., Liu H., Gong W., Jia Z., Zhang X., Dugarjaviin M., Bai D. Muscle Fibre Transition and Transcriptional Changes of Horse Skeletal Muscles during Traditional Mongolian Endurance Training. Equine Vet. J. 2024;56:178–192. doi: 10.1111/evj.13968. [DOI] [PubMed] [Google Scholar]
  • 25.Xing J., Qi X., Liu G., Li X., Gao X., Bou G., Bai D., Zhao Y., Du M., Dugarjaviin M., et al. A Transcriptomic Regulatory Network among miRNAs, lncRNAs, circRNAs, and mRNAs Associated with L-Leucine-Induced Proliferation of Equine Satellite Cells. Animals. 2023;13:208. doi: 10.3390/ani13020208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wan L., Chen G., Jian S., Yin X.J., Zhu H. Antioxidant and Xanthine Oxidase Inhibitory Properties and LC-MS/MS Identification of Compounds of Ethanolic Extract from Mulberry Leaves. Acta Sci. Pol. Technol. Aliment. 2018;17:313–319. doi: 10.17306/J.AFS.2018.0587. [DOI] [PubMed] [Google Scholar]
  • 27.Xia P., Gao X., Duan L., Zhang W., Sun Y.-F. Mulberrin (Mul) Reduces Spinal Cord Injury (SCI)-Induced Apoptosis, Inflammation and Oxidative Stress in Rats via miroRNA-337 by Targeting Nrf-2. Biomed. Pharmacother. 2018;107:1480–1487. doi: 10.1016/j.biopha.2018.07.082. [DOI] [PubMed] [Google Scholar]
  • 28.Giers J., Bartel A., Kirsch K., Müller S.F., Horstmann S., Gehlen H. Blood-Based Assessment of Oxidative Stress, Inflammation, Endocrine and Metabolic Adaptations in Eventing Horses Accounting for Plasma Volume Shift after Exercise. Vet. Med. Sci. 2024;10:e1409. doi: 10.1002/vms3.1409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Saidi K., Abderrahman A.B., Hackney A.C., Bideau B., Zouita S., Granacher U., Zouhal H. Hematology, Hormones, Inflammation, and Muscle Damage in Elite and Professional Soccer Players: A Systematic Review with Implications for Exercise. Sports Med. 2021;51:2607–2627. doi: 10.1007/s40279-021-01522-w. [DOI] [PubMed] [Google Scholar]
  • 30.Andriichuk A., Tkachenko H. Effect of Gender and Exercise on Haematological and Biochemical Parameters in Holsteiner Horses. J. Anim. Physiol. Anim. Nutr. 2017;101:e404–e413. doi: 10.1111/jpn.12620. [DOI] [PubMed] [Google Scholar]
  • 31.Valle E., Zanatta R., Odetti P., Traverso N., Furfaro A., Bergero D., Badino P., Girardi C., Miniscalco B., Bergagna S., et al. Effects of Competition on Acute Phase Proteins and Lymphocyte Subpopulations—Oxidative Stress Markers in Eventing Horses. J. Anim. Physiol. Anim. Nutr. 2015;99:856–863. doi: 10.1111/jpn.12289. [DOI] [PubMed] [Google Scholar]
  • 32.Hines M.T., Schott H.C., Bayly W.M., Leroux A.J. Exercise and Immunity: A Review with Emphasis on the Horse. J. Vet. Intern. Med. 1996;10:280–289. doi: 10.1111/j.1939-1676.1996.tb02063.x. [DOI] [PubMed] [Google Scholar]
  • 33.Neves P.R.D.S., Tenório T.R.D.S., Lins T.A., Muniz M.T.C., Pithon-Curi T.C., Botero J.P., Do Prado W.L. Acute Effects of High- and Low-Intensity Exercise Bouts on Leukocyte Counts. J. Exerc. Sci. Fit. 2015;13:24–28. doi: 10.1016/j.jesf.2014.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Cerqueira É., Marinho D.A., Neiva H.P., Lourenço O. Inflammatory Effects of High and Moderate Intensity Exercise—A Systematic Review. Front. Physiol. 2020;10:1550. doi: 10.3389/fphys.2019.01550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Scalco R.S., Snoeck M., Quinlivan R., Treves S., Laforét P., Jungbluth H., Voermans N.C. Exertional Rhabdomyolysis: Physiological Response or Manifestation of an Underlying Myopathy? BMJ Open Sport Exerc. Med. 2016;2:e000151. doi: 10.1136/bmjsem-2016-000151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Sarniak A., Lipińska J., Tytman K., Lipińska S. Endogenous Mechanisms of Reactive Oxygen Species (ROS) Generation. Postep. Hig. I Med. Dosw. 2016;70:1150–1165. doi: 10.5604/17322693.1224259. [DOI] [PubMed] [Google Scholar]
  • 37.Latham C.M., Dickson E.C., Owen R.N., Larson C.K., White-Springer S.H. Complexed Trace Mineral Supplementation Alters Antioxidant Activities and Expression in Response to Trailer Stress in Yearling Horses in Training. Sci. Rep. 2021;11:7352. doi: 10.1038/s41598-021-86478-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Codazza D., Maffeo G., Redaelu G. Serum Enzyme Changes and Haemato-Chemical Levels in Thoroughbreds after Transport and Exercise. J. S. Afr. Vet. Assoc. 1974;45:331–334. [Google Scholar]
  • 39.James C., Dugan C.W., Boyd C., Fournier P.A., Arthur P.G. Temporal Tracking of Cysteine 34 Oxidation of Plasma Albumin as a Biomarker of Muscle Damage Following a Bout of Eccentric Exercise. Eur. J. Appl. Physiol. 2024;124:2639–2650. doi: 10.1007/s00421-024-05488-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Kawamura T., Muraoka I. Exercise-Induced Oxidative Stress and the Effects of Antioxidant Intake from a Physiological Viewpoint. Antioxidants. 2018;7:119. doi: 10.3390/antiox7090119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Quetglas-Llabrés M.M., Monserrat-Mesquida M., Bouzas C., García S., Argelich E., Casares M., Ugarriza L., Llompart I., Tur J.A., Sureda A. Impact of Adherence to the Mediterranean Diet on Antioxidant Status and Metabolic Parameters in NAFLD Patients: A 24-Month Lifestyle Intervention Study. Antioxidants. 2024;13:480. doi: 10.3390/antiox13040480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Ighodaro O.M., Akinloye O.A. First Line Defence Antioxidants-Superoxide Dismutase (SOD), Catalase (CAT) and Glutathione Peroxidase (GPX): Their Fundamental Role in the Entire Antioxidant Defence Grid. Alex. J. Med. 2018;54:287–293. doi: 10.1016/j.ajme.2017.09.001. [DOI] [Google Scholar]
  • 43.Hargreaves B.J., Kronfeld D.S., Waldron J.N., Lopes M.A., Gay L.S., Saker K.E., Cooper W.L., Sklan D.J., Harris P.A. Antioxidant Status and Muscle Cell Leakage during Endurance Exercise. Equine Vet. J. 2002;34:116–121. doi: 10.1111/j.2042-3306.2002.tb05402.x. [DOI] [PubMed] [Google Scholar]
  • 44.Williams C.A., Kronfeldt D.S., Hess T.M., Saker K.E., Waldron J.N., Crandell K.M., Hoffman R.M., Harris P.A. Antioxidant Supplementation and Subsequent Oxidative Stress of Horses during an 80-Km Endurance Race. J. Anim. Sci. 2004;82:588–594. doi: 10.2527/2004.822588x. [DOI] [PubMed] [Google Scholar]
  • 45.Marlin D.J., Fenn K., Smith N., Deaton C.D., Roberts C.A., Harris P.A., Dunster C., Kelly F.J. Changes in Circulatory Antioxidant Status in Horses during Prolonged Exercise. J. Nutr. 2002;132:1622S–1627S. doi: 10.1093/jn/132.6.1622S. [DOI] [PubMed] [Google Scholar]
  • 46.Lim H.H., Lee S.O., Kim S.Y., Yang S.J., Lim Y. Anti-Inflammatory and Antiobesity Effects of Mulberry Leaf and Fruit Extract on High Fat Diet-Induced Obesity. Exp. Biol. Med. 2013;238:1160–1169. doi: 10.1177/1535370213498982. [DOI] [PubMed] [Google Scholar]
  • 47.Meijnikman A.S., Davids M., Herrema H., Aydin O., Tremaroli V., Rios-Morales M., Levels H., Bruin S., de Brauw M., Verheij J., et al. Microbiome-Derived Ethanol in Nonalcoholic Fatty Liver Disease. Nat. Med. 2022;28:2100–2106. doi: 10.1038/s41591-022-02016-6. [DOI] [PubMed] [Google Scholar]
  • 48.Clifford M.N. Diet-Derived Phenols in Plasma and Tissues and Their Implications for Health. Planta Med. 2004;70:1103–1114. doi: 10.1055/s-2004-835835. [DOI] [PubMed] [Google Scholar]
  • 49.Carey C.C., Lucey A., Doyle L. Flavonoid Containing Polyphenol Consumption and Recovery from Exercise-Induced Muscle Damage: A Systematic Review and Meta-Analysis. Sports Med. 2021;51:1293–1316. doi: 10.1007/s40279-021-01440-x. [DOI] [PubMed] [Google Scholar]
  • 50.Forman H.J., Davies K.J.A., Ursini F. How Do Nutritional Antioxidants Really Work: Nucleophilic Tone and Para-Hormesis versus Free Radical Scavenging in Vivo. Free Radic. Biol. Med. 2014;66:24–35. doi: 10.1016/j.freeradbiomed.2013.05.045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Owens D.J., Twist C., Cobley J.N., Howatson G., Close G.L. Exercise-Induced Muscle Damage: What Is It, What Causes It and What Are the Nutritional Solutions? Eur. J. Sport Sci. 2019;19:71–85. doi: 10.1080/17461391.2018.1505957. [DOI] [PubMed] [Google Scholar]
  • 52.Takada F., Woude D.L.V., Tong H.-Q., Thompson T.G., Watkins S.C., Kunkel L.M., Beggs A.H. Myozenin: An α-Actinin- and γ-Filamin-Binding Protein of Skeletal Muscle Z Lines. Proc. Natl. Acad. Sci. USA. 2001;98:1595–1600. doi: 10.1073/pnas.98.4.1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kong L., Yuan C., Guo T., Sun L., Liu J., Lu Z. Inhibitor of Myom3 Inhibits Proliferation and Promotes Differentiation of Sheep Myoblasts. Genomics. 2024;116:110921. doi: 10.1016/j.ygeno.2024.110921. [DOI] [PubMed] [Google Scholar]
  • 54.Feng L., Chen Z., Bian H. Skeletal Muscle: Molecular Structure, Myogenesis, Biological Functions, and Diseases. MedComm. 2024;5:e649. doi: 10.1002/mco2.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Braun T., Gautel M. Transcriptional Mechanisms Regulating Skeletal Muscle Differentiation, Growth and Homeostasis. Nat. Rev. Mol. Cell Biol. 2011;12:349–361. doi: 10.1038/nrm3118. [DOI] [PubMed] [Google Scholar]
  • 56.Mishima T., Takenaka Y., Hashimoto-Hachiya A., Tanigawa Y., Suzuki N., Oishi K., Ogasawara R. Time-of-Day Effect of High-Intensity Muscle Contraction on mTOR Signaling and Protein Synthesis in Mice. Sci. Rep. 2025;15:23702. doi: 10.1038/s41598-025-06709-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., Poueymirou W.T., Panaro F.J., Na E., Dharmarajan K., et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy. Science. 2001;294:1704–1708. doi: 10.1126/science.1065874. [DOI] [PubMed] [Google Scholar]
  • 58.Yoshida T., Delafontaine P. Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy. Cells. 2020;9:1970. doi: 10.3390/cells9091970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Girardi F., Taleb A., Ebrahimi M., Datye A., Gamage D.G., Peccate C., Giordani L., Millay D.P., Gilbert P.M., Cadot B., et al. TGFβ Signaling Curbs Cell Fusion and Muscle Regeneration. Nat. Commun. 2021;12:750. doi: 10.1038/s41467-020-20289-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Sartori R., Sandri M. Bone and Morphogenetic Protein Signalling and Muscle Mass. Curr. Opin. Clin. Nutr. Metab. Care. 2015;18:215–220. doi: 10.1097/MCO.0000000000000172. [DOI] [PubMed] [Google Scholar]
  • 61.Huang Z., Dai H., Li S., Wang Z., Wei Q., Ning Z., Guo Y., Shi F., Lv Z. Maternal Supplementation with Mulberry-Leaf Flavonoids Improves the Development of Skeletal Muscle in the Offspring of Chickens. Anim. Nutr. 2024;18:72–83. doi: 10.1016/j.aninu.2024.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Zhang L., Su S., Zhu Y., Guo J., Guo S., Qian D., Ouyang Z., Duan J. Mulberry Leaf Active Components Alleviate Type 2 Diabetes and Its Liver and Kidney Injury in Db/Db Mice through Insulin Receptor and TGF-β/Smads Signaling Pathway. Biomed. Pharmacother. 2019;112:108675. doi: 10.1016/j.biopha.2019.108675. [DOI] [PubMed] [Google Scholar]
  • 63.Delaney K., Kasprzycka P., Ciemerych M.A., Zimowska M. The Role of TGF-Β1 during Skeletal Muscle Regeneration. Cell Biol. Int. 2017;41:706–715. doi: 10.1002/cbin.10725. [DOI] [PubMed] [Google Scholar]
  • 64.Ligi D., Croce L., Mosti G., Raffetto J.D., Mannello F. Chronic Venous Insufficiency: Transforming Growth Factor-β Isoforms and Soluble Endoglin Concentration in Different States of Wound Healing. Int. J. Mol. Sci. 2017;18:2206. doi: 10.3390/ijms18102206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Fernandes S., Oliver-De La Cruz J., Morazzo S., Niro F., Cassani M., Ďuríková H., Caravella A., Fiore P., Azzato G., De Marco G., et al. TGF-β Induces Matrisome Pathological Alterations and EMT in Patient-Derived Prostate Cancer Tumoroids. Matrix Biol. 2024;125:12–30. doi: 10.1016/j.matbio.2023.11.001. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

animals-16-01548-s001.zip (444.4KB, zip)

Data Availability Statement

All data generated or analyzed during this study are included in this published article.


Articles from Animals : an Open Access Journal from MDPI are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES